Botanix Pharmaceuticals Limited
BXPHF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$19.92M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $19.92 Million |
|---|---|
| Enterprise Value | $-1,934,614.00 |
| Earnings per Share | $-0.03 |
| Beta | 0.86 |
| Outstanding Shares | 2,386,254,587 |
Return
| Return on Equity | -246.09% |
|---|---|
| Return on Assets | -147.51% |
| Return on Invested Capital | -203.18% |
Valuation & Multiples
| P/E Ratio | -0.31 |
|---|---|
| PEG | 0.91 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.05 |
| Enterprise Value to EBIT | 0.01 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -7.61 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
$11.76 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 3, 2027
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
$15.74 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Botanix Pharmaceuticals Limited
11 employees
CEO: Howie McKibbon
Botanix Pharmaceuticals Limited, an Australian enterprise, is dedicated to the discovery and advancement of novel dermatological and antimicrobial therapeutic agents. The company's central mission involves pioneering innovative treatment...